Unexplored therapeutic opportunities in the human genome

Oprea, Tudor I., Bologa, Cristian G., Brunak, Søren, Campbell, Allen, Gan, Gregory N., Gaulton, Anna, Gomez, Shawn M., Guha, Rajarshi +33 more·2018·Nature Reviews Drug Discovery

Cited by (378)

Items 201–300 of 378

  1. Recent Developments in the Optical Control of Adrenergic Signaling
    Shuang Shi, Yangzhi Cao, Maikel Wijtmans, Henry F. Vischer, Rob Leurs · 2025 · Medicinal Research Reviews
  2. Computational approaches in drug discovery and design
    Priyanka Sharma, Kalicharan Sharma, Mukesh Nandave · 2023 · Elsevier eBooks
  3. A dive into the unknome
    Juri Rappsilber · 2023 · Trends in Genetics
  4. Identification and Benchmarking of Myokinasib-II as a Selective and Potent Chemical Probe for Exploring MLCK1 Inhibition
    Gautam Kumar, Prema Kumari Agarwala, Aswin T. Srivatsav, Ashok Ravula, G. Ashmitha, Sreenath Balakrishnan, Shobhna Kapoor, Rishikesh Narayan · 2024 · ACS Chemical Biology
  5. Can BDDCS illuminate targets in drug design?
    Giovanni Bocci, Leslie Z. Benet, Tudor Ionel Oprea · 2019 · Drug Discovery Today
  6. Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles
    Jason Michael Conley, Hongmao Sun, Kristin L. Ayers, Hu Zhu, Rong Chen, Min Shen, Matthew D. Hall, Hongxia Ren · 2021 · Journal of Biological Chemistry
  7. Recent advances on the inhibition of human solute carriers: Therapeutic implications and mechanistic insights
    Nicholas J. D. Wright, Seok‐Yong Lee · 2022 · Current Opinion in Structural Biology
  8. Expanding chemogenomic space using chemoproteomics
    Lyn H. Jones · 2019 · Bioorganic & Medicinal Chemistry
  9. The Urgent Need for Management of Biological Samples and Data Accessibility in Latin America
    Rodrigo José Vargas, Óscar Cobar · 2021 · Frontiers in Pharmacology
  10. Selective Inhibition of Cysteine-Dependent Enzymes by Bioorthogonal Tethering
    Luke A. Spear, Yang Huang, Jinghao Chen, Alexander R. Nödling, Satpal Virdee, Yu‐Hsuan Tsai · 2022 · Journal of Molecular Biology
  11. Ultrasmall Chemogenetic Tags with Group‐Transfer Ligands
    Vedagopuram Sreekanth, Shaimaa H. Sindi, Santosh Kumar Chaudhary et al. · 2025 · Angewandte Chemie International Edition
  12. The evolving global landscape of first-in-class oncology drug innovation
    Xiangyun Mao, Zhaoqing Wang, Shu Kong, Yue Yang, Nancy A Dreyer, Yi Ba, Michael T. Lotze, Qimin Zhan, Guanqiao Li · 2026 · Signal Transduction and Targeted Therapy
  13. Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
    Adhikari, Bikash, Schneider, Katharina, Diebold, Mathias, Sotriffer, Christoph, Wolf, Elmar · 2024 · eLife
  14. Illuminating the Chemical Space of Untargeted Proteins
    Maria J. Falaguera, Jordi Mestres · 2023 · Journal of Chemical Information and Modeling
  15. Pharmacological approaches to understanding protein kinase signaling networks
    Elloise H. Stephenson, Jonathan M.G. Higgins · 2023 · Frontiers in Pharmacology
  16. Systematic Evaluation of Protein-Small Molecule Hybrids on the Yeast Surface
    Manjie Huang, Marina Rueda-Garcia, Abbigael Harthorn · 2024 · ACS Chemical Biology
  17. Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors
    Chinmaya U. Joisa, Kevin A. Chen, Matthew E. Berginski, Brian T. Golitz, Madison R. Jenner, Gabriela Herrera Loeza, Jen Jen Yeh, Shawn M. Gomez · 2023 · PeerJ
  18. Kinome state is predictive of cell viability in pancreatic cancer tumor and stroma cell lines
    Matthew E. Berginski, Madison R. Jenner, Chinmaya U. Joisa, Silvia G. Hererra, Brian T. Golitz, Matthew B. Lipner, John R Leary, Naim U. Rashid, Gary L. Johnson, Jen Jen Yeh et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  19. CryptoBank: A resource for the identification and prediction of cryptic sites in proteins
    Pedro Febrer Martinez, Thorben Fröhlking, Alberto Borsatto, Vladimiras Oleinikovas, Antonija Kuzmanic, Francesco Luigi Gervasio · 2026 · Science Advances
  20. The limitations of small molecule and genetic screening in phenotypic drug discovery
    Fabien Vincent, Davide Gianni · 2025 · Cell chemical biology
  21. Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system
    Howell Leung, Chengchen Duan, Wenhao Gou, Jianjiu Chen, Ying Xin, Zetian Zheng, Vladimir Naumov, David G. Gennert, Man Zhang, Alex Aliper et al. · 2026 · Scientific Reports
  22. Proteome-Wide Identification and Comparison of Drug Pockets for Discovering New Drug Indications and Side Effects
    Renxin Zhang, Zhiyuan Chen, Shuhan Li, Haohao Lv, Jinjun Li, Naixue Yang, Shao‐Xing Dai · 2025 · Molecules
  23. GeneSetCart: assembling, augmenting, combining, visualizing, and analyzing gene sets
    Giacomo B. Marino, Stephanie Olaiya, John Erol Evangelista, Daniel J. B. Clarke, Avi Ma’ayan · 2025 · GigaScience
  24. Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity
    Joshua C. Gray, Mikela A. Murphy, Lorenzo Leggio · 2020 · Drug and Alcohol Dependence
  25. Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein
    Tyng Hwey Tan, Elizabeth Patton, Carol A. Munro, Dora Corzo-León, A.J. Porter, Soumya Palliyil · 2021 · Viruses
  26. Innovative strategies for measuring kinase activity to accelerate the next wave of novel kinase inhibitors
    Tim S. Veth, Nynke M. Kannegieter, Erik L. de Graaf, Rob Ruijtenbeek, Jos Joore, Anna Ressa, Maarten A. F. Altelaar · 2024 · Drug Discovery Today
  27. Development of an In Situ G Protein-Coupled Receptor Fragment Molecule Screening Approach with High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance
    Enzo Petracco, Guillaume Ferré, Ivo Kabelka, Flavio Ballante, Jens Carlsson, Emma Mulry, Arka Prabha Ray, James H. P. Collins, Florent Allais, Matthew T. Eddy · 2025 · ACS Chemical Biology
  28. TractaViewer: a genome-wide tool for preliminary assessment of therapeutic target druggability
    Neil Pearson, Karim Malki, David A. Price Evans · 2019 · Bioinformatics
  29. An optimized NGS sample preparation protocol for in vitro CRISPR screens
    Corrin A. Wohlhieter, Fathema Z. Uddin, Àlvaro Quintanal-Villalonga · 2021 · STAR Protocols
  30. Profiling Sulfur(VI) Fluorides as Reactive Functionalities for Chemical Biology Tools and Expansion of the Ligandable Proteome
    Katharine E. Gilbert, Aini Vuorinen, Arron Aatkar et al. · 2022 · ChemRxiv
  31. Meta-Research: understudied genes are lost in a leaky pipeline between genome-wide assays and reporting of results
    2023
  32. Illuminating Dark Proteins using Reactome Pathways
    Timothy Brunson, Nasim Sanati, Lisa R. Matthews, Robin Haw, Deidre Beavers, Solomon I. Shorser, Cristoffer Sevilla, Guilherme Viteri, Patrick Conley, Karen Rothfels et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Degradation of G-quadruplex-binding proteins in chromatin using G4-ligand-based proteolysis-targeting chimeras
    Zixuan Wang, Xuan He, Xiaoyun Zhang, Jochen Spiegel, Sean M. Flynn, Shankar Balasubramanian · 2026 · Nature Chemistry
  34. Pathway-based, reaction-specific annotation of disease variants for elucidation of molecular phenotypes
    2024
  35. Zmat2 in mammals: conservation and diversification among genes and Pseudogenes
    Peter S. Rotwein, Kabita Baral · 2020 · BMC Genomics
  36. Data-Driven Analysis of Fluorination of Ligands of Aminergic G Protein Coupled Receptors
    Wojciech Pietruś, Rafał Kurczab, Dagmar Stumpfe, Andrzej Jacek Bojarski, Jürgen Bajorath · 2021 · Biomolecules
  37. The CFDE Workbench: Integrating Metadata and Processed Data from Common Fund Programs
    John Erol Evangelista, Daniel J.B. Clarke, Zhuorui Xie, Stephanie Olaiya, 김희수, Giacomo B. Marino, Anna I. Byrd, Shivaramakrishna Srinivasan, Sumana Srinivasan, Mano Ram Maurya et al. · 2026 · Journal of Molecular Biology
  38. pyGOMoDo: GPCRs modeling and docking with python
    Rui Pedro Ribeiro, Alejandro Giorgetti · 2023 · Bioinformatics
  39. AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK
    Essegian, Derek J., Chavez, Valery, Khurshid, Rabia, Merchan, Jaime R., Schürer, Stephan C. · 2023 · PLOS Computational Biology
  40. Predicting protein and pathway associations for understudied dark kinases using pattern-constrained knowledge graph embedding
    Mariah Victoria Salcedo, Nathan Gravel, Abbas Keshavarzi, Liang‐Chin Huang, Krzysztof Kochut, Natarajan Kannan · 2023 · PeerJ
  41. Functional unknomics: closing the knowledge gap to accelerate biomedical research
    Joao Rocha, Satish Arcot Jayaram, Tim J. Stevens, Nadine Muschalik, Rajen D. Shah, Sahar Emran, Cristina Robles, Matthew Freeman, Sean Munro · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
    Adhikari, Bikash, Schneider, Katharina, Diebold, Mathias, Sotriffer, Christoph, Wolf, Elmar · 2024 · eLife
  43. Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
    Ojeda, Samuel, Wang, Meng, Baek, Kheewoong, Bourgeois, Wallace, Sommerschield, Alba, Yue, Hong, Metivier, Rebecca J., Karagiannis, Panos, Levitz, Talya S., Xiong, Yuan et al. · 2026 · Science
  44. Polypharmacological profiling across protein target families and cellular pathways using the multiplexed cell-based assay platform safetyProfiler reveals efficacy, potency and side effects of drugs
    Lukša Popović, Ben Brankatschk, Giulia Palladino, Moritz J. Rossner, Michael C. Wehr · 2024 · Biomedicine & Pharmacotherapy
  45. Nanoparticulate delivery and targeting of RNA to the brain
    Aditya Gupta, Raghu Ramanathan, Chittalsinh M Raulji, Ram I. Mahato · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  46. Atomic-level protein–ligand recognition with PBCNet2.0 for probe discovery
    Jie Yu, Xia Sheng, Zhehuan Fan, Zhaokun Wang, Duanhua Cao, Yufan Tang, Yongxin Hao, Yingying Zhang, Panpan Shao, Huicong Ma et al. · 2026 · Nature Chemical Biology
  47. Reverse tracking from drug-induced transcriptomes through multilayer molecular networks reveals hidden drug targets
    Gwangmin Kim, Doheon Lee · 2023 · Computers in Biology and Medicine
  48. Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines
    Matthew E. Berginski, Madison R. Jenner, Chinmaya U. Joisa, Gabriela Herrera Loeza, Brian T. Golitz, Matthew B. Lipner, Jack R. Leary, Naim Rashid, Gary L. Johnson, Jen Jen Yeh et al. · 2024 · PeerJ
  49. Fab-Induced Stabilization of an Ion Channel Receptor Enables Mechanistic Characterization of Small-Molecule Therapeutics
    Soo Y. Ro, Christine C. Jao, Angela Oh, Marc Kschonsak, Tianbo Li, Daniel Austin, Demi Maria Zabala Greiner, Lijuan Zhou, Yingnan Zhang, Jun Chen et al. · 2025 · Analytical Chemistry
  50. What Features of Ligands Are Relevant to the Opening of Cryptic Pockets in Drug Targets?
    Zhonghua Xia, Pavel Karpov, Grzegorz M. Popowicz, Michael Sattler, Igor V. Tetko · 2022 · Informatics
  51. Multivariate phenotype analysis enables genome-wide inference of mammalian gene function
    George Nicholson, Hugh Morgan, Habib Ganjgahi, Steve D. M. Brown, Ann‐Marie Mallon, Chris C. Holmes · 2022 · PLoS Biology
  52. Small molecule modulation of microbiota: a systems pharmacology perspective
    Qiao Liu, Bohyun Lee, Lei Xie · 2022 · BMC Bioinformatics
  53. A novel chemical attack on Notch-mediated transcription by targeting the NACK ATPase
    Giulia Diluvio, Tanya T. Kelley, Mohini Lahiry, Annamil Alvarez-Trotta, Ellen K. Gagliani, Elena Shersher, Luisana Astudillo, Rhett A. Kovall, Stephan C. Schürer, Anthony J. Capobianco · 2023 · Molecular Therapy — Oncolytics
  54. Proteomic Research on the Therapeutic Properties of Medicinal Mushrooms
    Boris Jakopović, Nada Oršolić, Sandra Kraljević Pavelić, Ivan Jakopovich · 2023 · Springer eBooks
  55. Clover: An unbiased method for prioritizing differentially expressed genes using a data‐driven approach
    Gina Miku Oba, Ryuichiro Nakato · 2024 · Genes to Cells
  56. Redirecting cytotoxic T cells with chemically programmed antibodies
    Junpeng Qi, Christoph M. Rader · 2020 · Bioorganic & Medicinal Chemistry
  57. Development and validation of multiple machine learning algorithms for the classification of G-protein-coupled receptors using molecular evolution model-based feature extraction strategy
    Cheng Ling, Xiaolin K. Wei, Yitian Shen · 2021 · Amino Acids
  58. Illuminate the Functions of Dark Proteins Using the Reactome‐IDG Web Portal
    Deidre Beavers, Timothy Brunson, Nasim Sanati et al. · 2023 · Current Protocols
  59. Advances in the molecular understanding of G protein-coupled receptors and their future therapeutic opportunities
    Daniel N. Obot, Godswill James Udom, Anwanabasi E. Udoh, Nkechi J. Onyeukwu, Ayobami J. Olusola, Ikanke M Udoh, Israel Kevin Umana, Omoniyi K. Yemitan, Jude Efiom Okokon · 2021 · Future Journal of Pharmaceutical Sciences
  60. Semantic Technologies in Drug Discovery
    Samantha Kanza, Jeremy Graham Frey · 2020 · Elsevier eBooks
  61. Profiling Sulfur(VI) Fluorides as Reactive Functionalities for Chemical Biology Tools and Expansion of the Ligandable Proteome
    Katharine E. Gilbert, Aini Vuorinen, Arron Aatkar · 2022 · ChemRxiv
  62. Chemoinformatics and Artificial Intelligence Colloquium: Progress and Challenges to Develop Bioactive Compounds
    Jürgen Bajorath, Ana L. Chávez‐Hernández, Miquel Duran‐Frigola, Eli Fernández‐de Gortari, Johann Gasteiger, Edgar López‐López, José L. Medina‐Franco, Oscar Méndez‐Lucio, Jordi Mestres, Ramón Alain Miranda‐Quintana et al. · 2022 · ChemRxiv
  63. The Data Distillery: A Graph Framework for Semantic Integration and Querying of Biomedical Data
    Taha Mohseni Ahooyi, Benjamin J. Stear, J. Alan Simmons, Vincent T. Metzger, Praveen Kumar, John Erol Evangelista, Daniel J. B. Clarke, Zhuorui Xie, Hee-Su Kim, Sherry L. Jenkins et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways
    Boris Jakopović, Anita Horvatić, Jurica Baranašić, Iris Car, Nada Oršolić, Ivan Jakopovich, Mirela Sedić, Sandra Kraljević Pavelić · 2024 · Frontiers in Pharmacology
  65. Translating multi-omics into healthcare: requisites for scalable and equitable implementation
    Biruté Tumiene, David R. Adams, Robert J. Allaway, María J. Barrero, Chun‐Hung Chan, Víctor Faùndes, Vanessa S. Fear, Polina Glezer, Claudia Fuchs, Tudor Groza et al. · 2026 · Human Genomics
  66. Small bioactive molecules designed to be probes as baits "fishing out" cellular targets: Finding the fish in the proteome sea
    Xiaoan Li, Jianzhong Jia, Qian FENG, Tiantian Bai, Pei Jin, Shaoping Wu, Yongmin Zhang · 2022 · Chinese Journal of Analytical Chemistry
  67. Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis
    Zhuorui Xie, Clara C. Chen, Avi Ma’ayan · 2023 · PeerJ
  68. Meta-Research: Understudied genes are lost in a leaky pipeline between genome-wide assays and reporting of results
    Richardson, Reese, Tejedor Navarro, Heliodoro, Amaral, Luis A Nunes, Stoeger, Thomas · 2024 · eLife
  69. Enantioselective Synthesis of α‐Quaternary Isochromanes by Oxidative Aminocatalysis and Gold Catalysis
    Philipp Waser, Jonas Faghtmann, Marta Gil‐Ordóñez, Anne Kristensen, Esben B. Svenningsen, Thomas Bjørnskov Poulsen, Karl Anker Jørgensen · 2024 · Chemistry - A European Journal
  70. Drug Design and Drug Discovery
    Aditya Maurya, Aditya Tripathi, Afsana Khatoon · 2024 · International Journal of Innovative Science and Research Technology (IJISRT)
  71. MolBiC: the cell-based landscape illustrating molecular bioactivities
    Yichao Ge, Mengjie Yang, Xinyuan Yu et al. · 2024 · Nucleic Acids Research
  72. Design, synthesis, and screening of an RNA optimized fluorinated fragment library
    Kasper P. Lundquist, Isabella Romeo, Raffaele Bellini Puglielli · 2025 · SLAS DISCOVERY
  73. The Study of Microbe–Host Two-Way Communication
    Famatta Perry, Ryan J. Arsenault · 2022 · Microorganisms
  74. Systematic classification of shared components of genetic risk for common human diseases
    Adrián Cortés, Calliope Athena Dendrou, Lars H. Fugger, Gil McVean · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  75. A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease
    Genevieve M Leyden, Tom R. Gaunt, Tom G. Richardson · 2020 · medRxiv
  76. PrismExp: Predicting Human Gene Function by Partitioning Massive RNA-seq Co-expression Data
    Alexander Lachmann, Kaeli Rizzo, Alon Bartal, Minji Jeon, Daniel J. B. Clarke, Avi Ma’ayan · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  77. NEK5 Activity Regulates the Mesenchymal and Migratory Phenotype in Breast Cancer Cells
    Margarite D. Matossian, Steven G. Elliott, Van T. Hoang et al. · 2021 · Research Square
  78. Broad functional profiling of fission yeast proteins using phenomics and machine learning
    Rodríguez-López, María, Bordin, Nicola, Lees, Jon, Scholes, Harry, Hassan, Shaimaa, Saintain, Quentin, Kamrad, Stephan, Orengo, Christine, Bähler, Jürg · 2023
  79. Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics
    George S. Biggs, Emma E. Cawood, Aini Vuorinen, William J. McCarthy, Harry Wilders, Ioannis G. Riziotis, Antonie J. van der Zouwen, Jonathan Pettinger, Luke Nightingale, Peiling Chen et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Advancing Ligand Binding Affinity Prediction with Cartesian Tensor-Based Deep Learning
    Jie Yu, Xia Sheng, Zhehuan Fan, Zhaokun Wang, Duanhua Cao, Yongxin Hao, Yingying Zhang, Panpan Shao, Huicong Ma, Tian Cao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Underexplored Molecular Mechanisms of Toxicity
    Olatunbosun K. Arowolo, Alexander Suvorov · 2024 · Journal of Xenobiotics
  82. Method development for potential drug target identification and drug discovery
    Daohong Gong, Jianxin Tang, Baoli Wang, Sutong Xiang, Ziyan Feng, Shiliang Li, Honglin Li · 2025 · Scientia Sinica Chimica
  83. TargetPair: A Single Cell-omics Resource of Clinical Trials-derived Therapeutical Target Combinations for Cancer Therapy
    Kaicheng Zhou, Xingxiu Li, Yuan Yang, Dongyue Hou, Shuaiqi Wang, Hanbo Lin, Ruining Yin, Dianwen Ju, Xian Liang Zeng, Shaofei Wang · 2025 · Journal of Molecular Biology
  84. Unveiling the Monoamine Oxidase Inhibitory Potential of Natural Flavonoids: A Computational Approach
    Zakiya Fathima C, Jainey Puthenveettil James, Vaishnavi Gatty · 2025 · Research Journal of Pharmacy and Technology
  85. Lysosome‐Targeting Chimeras (LYTACs): From Modular Design Principles to Diverse Therapeutic Applications
    Zhihui Zhou, Q Niu, Xiyuan Yu, Chaoyong James Yang, Zhi Zhu · 2026 · Chemistry - A European Journal
  86. Clone-By-Clone Therapy Guidance in Luminal Breast Cancer Via Spatial Proteomics and Patient-Derived Tumoroid
    Laurine Lagache, Antonella Raffo Romero, Marie Duhamel · 2026 · Molecular & Cellular Proteomics
  87. The Zmat2 gene in non-mammalian vertebrates: Organizational simplicity within a divergent locus in fish
    Peter S. Rotwein · 2020 · PLoS ONE
  88. Targeted Protein Degradation Chemical Probes
    Carles Galdeano, Xavier Barril · 2020 · Royal Society of Chemistry eBooks
  89. Immunogenicity of Therapeutic Proteins
    Mohammad Yasir, Alok Shiomurti Tripathi, Prashant Shukla · 2023 · Springer eBooks
  90. Lead Generation
    Frank Narjes, Garry Pairaudeau, Dušan Petrović · 2023 · Royal Society of Chemistry eBooks
  91. Shedding a Light on Dark Genes: A Comparative Expression Study of PRR12 Orthologues during Zebrafish Development
    Alessia Muscò, Davide Martini, Matteo Digregorio, Vania Broccoli, Massimiliano Andreazzoli · 2024 · Genes
  92. Moonlighting Proteins: Importance and Current Scenarios
    Ana Carolina Franco Severo Martelli, Beatriz Brambila, Mariana Pegrucci Barcelos, Flávia da Silva Zandonadi, Solange Cristina Antão, André Vessoni Alexandrino, Carlos Henrique Tomich de Paula da Silva, Maria Teresa Marques Novo‐Mansur · 2024 · Engineering materials
  93. Pharmacological Target Engagement and Validation
    Terry Kenakin · 2021 · Elsevier eBooks
  94. PROSPECTS OF USING CELL-FREE PROTEIN SYNTHESIS IN BIOTECHNOLOGY
    I. S. Kazlouski · 2021 · Микробные биотехнологии фундаментальные и прикладные аспекты
  95. PKMYT1 is a computationally predicted target for kidney cancer
    Denis Torre, Nicolas Fernandez, Avi Ma’ayan · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Moving Targets: Monitoring Target Trends in Drug Discovery by Mapping Targets, GO Terms, and Diseases
    Barbara Zdrazil, Lars Richter, Nathan Brown · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  97. A Structural View on Druggability
    Ursula Egner, Roman Christian Hillig · 2020 · Wiley eBooks
  98. In silico protein science: from sequence to network
    Miguel Correa Marrero · 2021
  99. Using BERT to identify drug-target interactions from whole PubMed
    Jehad Aldahdooh, Markus J. V. Vähä-Koskela, Jing Ping Tang, Ziaurrehman Tanoli · 2021 · Research Square
  100. AlphaFold Models Illuminate Half of Dark Human Proteins
    Jessica Binder, Joel Berendzen, Amy O. Stevens, Yi Jie He, Jian Wang, Nikolay V. Dokholyan, Tudor Ionel Oprea · 2021 · bioRxiv (Cold Spring Harbor Laboratory)